Viewing Study NCT05626257

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2026-01-30 @ 11:17 PM
Study NCT ID: NCT05626257
Status: COMPLETED
Last Update Posted: 2025-11-21
First Post: 2022-11-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Rhinosinusitis With Nasal Polyps View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Rhinosinusitis with Nasal Polyps View
None CRSwNP View
None Korea View
None NIS View
None Xolair View